TiGenix bulks up in merger with Cellerix
This article was originally published in Scrip
Executive Summary
Belgian firm TiGenix has agreed to merge with Cellerix, a Spanish company specialising in adipose tissue-derived stem cell therapies, in a bid to gain critical mass in the regenerative medicine market.